Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Gastroenterology

• Publication date

  1998-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00042737-199901000-00016PMID 9753483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prospective evaluation of neutrophil autoantibodies in 500 consecutive patients with inflammatory bowel disease.

  1997cited by this paper
• Nutritional therapy for Crohn's disease: lessons from the ste.-Justine hospital experience.

  1997cited by this paper
• Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway.

  1997cited by this paper
• Specific antibody response to oligomannosidic epitopes in Crohn's disease

  1996cited by this paper
• Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup.

  1996cited by this paper
• Crohn's Disease in Children 10 Years Old and Younger: Comparison with Ulcerative Colitis

  1994cited by this paper
• Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity.

  1994cited by this paper
• Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis.

  1994cited by this paper
• Incidence and prevalence of inflammatory bowel disease in children in South‐Western Sweden

  1994cited by this paper
• Ulcerative colitis in children 10 years old or younger.

  1993cited by this paper
• Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance.

  1992cited by this paper
• Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role.

  1992cited by this paper
• Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses.

  1991cited by this paper
• A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease.

  1990cited by this paper
• Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease.

  1990cited by this paper
• Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.

  1988cited by this paper
• Histological diagnosis of chronic inflammatory bowel disease in childhood.

  1985cited by this paper
• Inflammatory bowel disease in childhood.

  1984cited by this paper
• Textbook of pediatric rheumatology

  1982cited by this paper
• A simple index of Crohn's-disease activity.

  1980cited by this paper
• Crohn's Disease

  1976cited by this paper
• Juvenile Rheumatoid Arthritis.

  1964cited by this paper
• Noradrenaline in Acute Peripheral Circulatory Failure

  1956cited by this paper

• Diagnostic accuracy of anti-integrin αvβ6 in ulcerative colitis: a diagnostic meta-analysis

  2025influential citation
• The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases

  2025cites this paper
• Decoding the role of gut mycobiota in immune regulation and disease

  2025cites this paper
• Serum Biomarkers in Diagnosis and Clinical Management of Inflammatory Bowel Disease: Anything New on the Horizon?

  2024cites this paper
• Epigenomics and the Brain-gut Axis: Impact of Adverse Childhood Experiences and Therapeutic Challenges

  2024cites this paper
• Diagnosis and management of inflammatory bowel disease

  2024cites this paper
• Role of Candida species in pathogenesis, immune regulation, and prognostic tools for managing ulcerative colitis and Crohn's disease

  2024cites this paper
• Mucosal Immunity to Gut Fungi in Health and Inflammatory Bowel Disease

  2023cites this paper
• From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health.

  2023cites this paper
• Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease

  2022cites this paper
• Inflammatory bowel disease biomarkers

  2022cites this paper
• Gastrointestinal disorder biomarkers.

  2022cites this paper
• Fungal microbiome in inflammatory bowel disease: a critical assessment

  2022cites this paper
• Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis

  2021cites this paper
• CLASSICAL SEROLOGICAL MARKERS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE IN BRAZIL.

  2021cites this paper
• The role of gut mycobiome in health and diseases

  2021cites this paper
• Ulcerative Colitis in Children and Adolescents

  2021cites this paper
• Sclerosing cholangitis and inflammatory bowel disease: which comes first?

  2021cites this paper
• Antibodies to Crohn’s disease peptide 353 as a diagnostic marker for pediatric Crohn’s disease: a prospective multicenter study in Japan

  2020cites this paper
• Serological antibodies and surgery in a population-based inception cohort of Crohn’s disease patients – the IBSEN study

  2020cites this paper
• Neutrophil Elastase and Neutrophil Extracellular Traps in the Tumor Microenvironment.

  2020cites this paper
• DDDT_A_218357 677..696

  2020cites this paper
• Evaluation of protein arginine deiminase-4 inhibitor in TNBS- induced colitis in mice.

  2020cites this paper
• Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn’s Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage

  2020cites this paper
• Medikamentöse Therapie der CED bei Kindern und Jugendlichen

  2020cites this paper
• Colon Targeting of Naringin for Enhanced Cytoprotection Against Indomethacin-Induced Colitis in Rabbits

  2020cites this paper
• Biomarkers in Inflammatory Bowel Diseases

  2019cites this paper
• Variation of Gut Mucosal Microbiome with ASCA Status in Pediatric Crohn's Disease.

  2019cites this paper
• Inflammatory Bowel Disease Serological Immune Markers Anti-Saccharomyces cerevisiae Mannan Antibodies and Outer Membrane Porin C are Potential Biomarkers for Hirschsprung-associated Enterocolitis.

  2019cites this paper
• Anti-Saccharomyces cerevisiae Antibodies as a Prognostic Biomarker in Children With Crohn Disease.

  2019cites this paper
• Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response

  2019cites this paper
• Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence

  2019cites this paper
• Personalized Medicine - Dream or Reality?

  2019cites this paper
• PEDIATRIC CROHN DISEASE: A CASE SERIES FROM A TERTIARY CARE CENTER

  2019cites this paper
• Postoperative Crohn’s Disease

  2019cites this paper
• IBD Serology in Pouch Disorders

  2019cites this paper
• Risk Factors for Chronic Inflammatory Disorders of Ileal Pouch

  2019cites this paper
• Biomarker discovery in inflammatory bowel diseases using network-based feature selection

  2019cites this paper
• Molecular diagnosis and classification of inflammatory bowel disease

  2018cites this paper
• Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course.

  2018cites this paper
• Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system

  2018cites this paper
• The evidence for fungus in Crohn’s disease pathogenesis

  2018cites this paper
• Retrospective evaluation of our 68 pediatric patients diagnosed with inflammatory bowel disease

  2018cites this paper
• Epidemiology of Crohn’s Disease in Japan

  2018cites this paper
• Crohn ' disease or intestinal tuberculosis , diagnostic dilemma-a case series

  2018cites this paper
• Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.

  2018cites this paper
• Intestinal Behçet and Crohn’s disease: two sides of the same coin

  2017cites this paper
• Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management

  2017cites this paper
• Pediatric Inflammatory Bowel Disease.

  2017cites this paper
• Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.

  2017cites this paper
• Laboratory Evaluation, Including Novel Diagnostic Markers

  2017cites this paper
• Pediatric Inflammatory Bowel Disease

  2017cites this paper
• Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA

  2017cites this paper
• An Update on Inflammatory Bowel Disease.

  2017cites this paper
• COMPOSITIONS AND METHODS USEFUL FOR THE TREATMENT AND DAGNOSIS OF NFLAMMLATORY BOWEL DISEASE

  2017cites this paper
• Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy

  2017cites this paper
• Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications

  2017cites this paper
• Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans

  2017cites this paper
• Cutaneous Small‐Vessel Vasculitis in Two Children with Inflammatory Bowel Disease: Case Series and Review of the Literature

  2017cites this paper
• Anticorps anti-Saccharomyces cerevisiae (ASCA) dans la spondyloarthrite : prévalence et phénotype associé

  2017cites this paper
• Inflammatory Bowel Diseases: How to Identify High-Risk Patients

  2017cites this paper
• Eosinophilic colitis in children

  2017cites this paper
• Current application of proteomics in biomarker discovery for inflammatory bowel disease.

  2016cites this paper
• Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthritis: Prevalence and associated phenotype.

  2016cites this paper
• Clinical utility of serodiagnostic testing in pediatric inflammatory bowel disease

  2016cites this paper
• Do antibodies select a healthy microbiota?

  2016cites this paper
• Antibody markers in the diagnosis of inflammatory bowel disease.

  2016cites this paper
• IBD: colite ulcerosa

  2016cites this paper
• New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes

  2016cites this paper
• DIAGNOSTIC AND PROGNOSTIC MICROBIAL BIOMARKERS IN IBD

  2015cites this paper
• Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.

  2015cites this paper
• So What Is Crohn’s Disease and Ulcerative Colitis? Pathophysiology of Crohn’s Disease and Ulcerative Colitis

  2015cites this paper
• pANCA Positivity Predicts Lower Clinical Response to Infliximab Therapy among Patients with IBD

  2015influential citation
• Characterization of gut associated circulating invariant natural killer T cells (iNKT) in chronic inflammation of the intestine

  2015cites this paper
• Diagnostic Modalities for Inflammatory Bowel Disease: Serologic Markers and Endoscopy.

  2015cites this paper
• Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease

  2015cites this paper
• Clinical aspects of indirect immunofluorescence for autoimmune diseases

  2015cites this paper
• Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis.

  2015cites this paper
• Anti‐Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease

  2015cites this paper
• Tuberculosis and Crohn's Disease Revisited.

  2015cites this paper
• Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.

  2015cites this paper
• Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine

  2015influential citation
• Anti- Saccharomyces cerevisiae Antibodies Autoimmune Diseases

  2015cites this paper
• New serological markers in pediatric patients with inflammatory bowel disease.

  2014cites this paper
• Clinical, Serologic, and Genetic Factors Associated with Pyoderma Gangrenosum and Erythema Nodosum in Inflammatory Bowel Disease Patients

  2014cites this paper
• The epidemiology, phenotype and disease course of Australian children with inflammatory bowel disease.

  2014cites this paper
• Inflammatory Bowel Diseases

  2014cites this paper
• [Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version)].

  2014cites this paper
• Optimisation de la réponse aux thiopurines par la pharmacogénétique : approches in vitro et cliniques

  2014cites this paper
• ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

  2013cites this paper
• Targeting Tissular Immune Response Improves Diagnostic Performance of Anti-Saccharomyces cerevisiae Antibodies (ASCA) in Crohn’s Disease

  2013cites this paper
• Proteomics and metabolomics in inflammatory bowel disease

  2013cites this paper
• Serum Antibodies Associated with Complex Inflammatory Bowel Disease

  2013cites this paper
• Biomarcatori nelle malattie infiammatorie intestinali

  2013cites this paper
• Association of Inflammatory Bowel Disease With Familial Mediterranean Fever in Turkish Children

  2013cites this paper
• Specific IgG Response against Mycobacterium avium paratuberculosis in Children and Adults with Crohn’s Disease

  2013cites this paper
• Circulating Antibodies against Bacterial Wall Products: Are There Arguments for Early Immunosuppression?

  2013cites this paper
• Laboratory Evaluation of Inflammatory Bowel Disease

  2013cites this paper
• Update in pediatric inflammatory bowel disease.

  2013cites this paper
• La maladie de Crohn de l'enfant

  2013cites this paper